Dipperam HCT 5 mg/160 mg/25 mg filmom obložene tablete
| Name | Dipperam HCT 5 mg/160 mg/25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-731274101 |
| Active Substance | amlodipinbesilat valsartan hidroklorotiazid |
| Composition | svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Salutas Pharma GmbH, Barleben, Njemačka Novartis Pharma GmbH, Nürnberg, Njemačka Novartis Farma S.p.A., Torre Annunziata (Napulj), Italija Novartis Farmacéutica S.A., Barcelona, Španjolska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 26.10.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/140 |
| Registration Number | 381-12-01/70-23-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DX01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
